IPO of Wintershall Dea will be targeted post 2021
The shareholders of Wintershall Dea – BASF and LetterOne – have decided to postpone the Initial Public Offering (IPO) to a later point in time.
The shareholders of Wintershall Dea – BASF and LetterOne – have decided to postpone the Initial Public Offering (IPO) to a later point in time.
Acquisition will nearly double Westlake’s building products business by adding leading brands in the premium roofing
The virtual summit will bring the best brains, policy makers, and major stakeholders from the BRICS nations deliberating and discussing at length the future of Hydrogen in the energy mix
Project is its first R&D center for nylon 6,6 application development in Asia with an investment of more than 95 million RMB ($15 million USD)
This product line is designed for methanol producers worldwide and is based on the well-proven copper-zinc-alumina system
OIL has reported total income of Rs.23589.72 crores during the 12 months period ended March 31, 2021
The company plans to launch 5-6 new products to drive growth in FY22
TTF price rise is also due to surge in EU carbon price, which improved coal to gas switching economics
Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline
The company believes that building a high-trust company culture and creating a positive work environment for all has helped GHCL navigate the challenges brought about by the COVID-19 pandemic
Jubilant Industries has reported total income of Rs.624.34 crores during the 12 months period ended March 31, 2021
The rating upgrade by the India Ratings and Research is a testament of DCW's improving financial and operating performance
The company plans to enhancement the capacity from 9,200 MTPA to 11,000 MTPA through de-bottlenecking
The company reported total income of Rs.267.37 crores during the 12 months period ended March 31, 2021
The company has reported total income of Rs.386.50 crores during FY 21
The company has posted net loss of Rs.(218.71) crores for the 12 months period ended March 31, 2021
The company has reported total income of Rs.1427.95 crores during the 12 months period ended March 31, 2021
The two will jointly develop the testing capacity and the RT-PCR CRISPR test will be done using the Tata MD CHECK SARS-CoV-2 test kits that are powered by FELUDA technology from CSIR-IGIB
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
She is the first woman functional director of ONGC in its history
Subscribe to our newsletter & stay updated.